MH Pharma Q Services: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MH Pharma Q Services
Largest movements
- Cash +€35,475
up €35,475 (+21.8%), from €162,706 to €198,181
mainly Net result for the year (+€40,445) and Depreciation (+€955)
- Reserves +€40,445
up €40,445 (+32.9%), from €122,901 to €163,346
- Gross operating margin -€19,849
down €19,849 (-24.7%), from €80,352 to €60,503
- Taxes -€5,446
down €5,446 (-25.9%), from €21,059 to €15,614
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €180,001 | €217,633 | +€37,632 | +20.9% |
| Fixed assets | 21/28 | €2,077 | €2,198 | +€120 | +5.8% |
| Tangible fixed assets | 22/27 | €2,077 | €2,198 | +€120 | +5.8% |
| Plant, machinery and equipment | 23 | €2,077 | €1,454 | -€623 | -30.0% |
| Furniture and vehicles | 24 | - | €744 | +€744 | |
| Current assets | 29/58 | €177,923 | €215,435 | +€37,512 | +21.1% |
| Amounts receivable within one year | 40/41 | €15,217 | €17,255 | +€2,037 | +13.4% |
| Trade receivables | 40 | €12,488 | €17,255 | +€4,767 | +38.2% |
| Other amounts receivable | 41 | €2,729 | - | -€2,729 | |
| Cash at bank and in hand | 54/58 | €162,706 | €198,181 | +€35,475 | +21.8% |
| Total equity and liabilities | 10/49 | €180,001 | €217,633 | +€37,632 | +20.9% |
| Equity | 10/15 | €125,401 | €165,846 | +€40,445 | +32.3% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €122,901 | €163,346 | +€40,445 | +32.9% |
| Distributable reserves | 133 | €122,901 | €163,346 | +€40,445 | +32.9% |
| Amounts payable | 17/49 | €54,600 | €51,787 | -€2,813 | -5.2% |
| Amounts payable within one year | 42/48 | €54,260 | €51,432 | -€2,828 | -5.2% |
| Trade debts | 44 | €3,989 | €2,999 | -€991 | -24.8% |
| Suppliers | 440/4 | €3,989 | €2,999 | -€991 | -24.8% |
| Taxes, remuneration and social security | 45 | €49,432 | €47,402 | -€2,030 | -4.1% |
| Taxes | 450/3 | €46,982 | €44,952 | -€2,030 | -4.3% |
| Remuneration and social security | 454/9 | €2,450 | €2,450 | = | 0.0% |
| Other amounts payable | 47/48 | €839 | €1,032 | +€193 | +23.0% |
| Accrued charges and deferred income | 492/3 | €340 | €355 | +€15 | +4.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €623 | €955 | +€332 | +53.3% |
| Other operating charges | 640/8 | €312 | €339 | +€27 | +8.7% |
| Gross operating margin | 9900 | €80,352 | €60,503 | -€19,849 | -24.7% |
| Operating profit (loss) | 9901 | €79,416 | €59,208 | -€20,208 | -25.4% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €3,848 | €3,150 | -€698 | -18.1% |
| Recurring financial charges | 65 | €3,848 | €3,150 | -€698 | -18.1% |
| Profit (loss) for the period before taxes | 9903 | €75,568 | €56,059 | -€19,509 | -25.8% |
| Income taxes | 67/77 | €21,059 | €15,614 | -€5,446 | -25.9% |
| Profit (loss) for the period | 9904 | €54,509 | €40,445 | -€14,064 | -25.8% |
| Profit (loss) for the period to be appropriated | 9905 | €54,509 | €40,445 | -€14,064 | -25.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.